Core Viewpoint - Xilong Science has shown a mixed performance in stock price and financial results, with a notable increase in stock price this year but a decline in revenue and net profit for the first nine months of 2025 [1][2]. Group 1: Stock Performance - On November 21, Xilong Science's stock rose by 2.05%, reaching 8.95 CNY per share, with a trading volume of 252 million CNY and a turnover rate of 6.08%, resulting in a total market capitalization of 5.238 billion CNY [1]. - Year-to-date, Xilong Science's stock price has increased by 24.48%, with a 3.95% rise over the last five trading days and a 4.19% increase over the last 20 days, while it has decreased by 2.72% over the last 60 days [1]. - The company has appeared on the "Dragon and Tiger List" five times this year, with the most recent appearance on September 24, where it recorded a net purchase of 3.6192 million CNY [1]. Group 2: Financial Performance - For the period from January to September 2025, Xilong Science reported a revenue of 5.324 billion CNY, a year-on-year decrease of 11.13%, and a net profit attributable to shareholders of -61.8292 million CNY, representing a year-on-year decline of 196.33% [2]. - The company's main business revenue composition includes specialized chemicals (62.60%), chemical raw materials (15.12%), electronic chemicals (9.66%), general reagents (7.71%), lithium battery cathode materials (4.00%), and raw materials and food additives (0.86%) [2]. Group 3: Shareholder Information - As of September 30, Xilong Science had 85,100 shareholders, a decrease of 2.33% from the previous period, with an average of 5,503 circulating shares per shareholder, an increase of 2.38% [2]. Group 4: Dividend Information - Since its A-share listing, Xilong Science has distributed a total of 217 million CNY in dividends, with 31.0165 million CNY distributed over the past three years [3].

Core Points - On November 20, Xilong Science executed a block trade of 2.237 million shares, with a transaction value of 17.471 million yuan, accounting for 4.32% of the total trading volume for the day [1] - The transaction price was 7.81 yuan, representing a discount of 10.95% compared to the market closing price of 8.77 yuan [1] Summary by Category Trading Details - The block trade on November 20 involved a total of 2.237 million shares at a price of 7.81 yuan per share [1] - The total transaction value was 17.471 million yuan, which is approximately 2.5 million USD [1] - The trade accounted for 4.32% of the total trading volume on that day [1] Buyer and Seller Information - The buyers included various securities firms such as Donghai Securities, Yuekai Securities, and Western Securities, with specific branches involved in the transactions [2] - The sellers included Guotai Junan Securities and Guolian Minsheng Securities, indicating a diverse trading environment [2]

Core Insights - On November 19, Xilong Science executed a block trade of 827,000 shares, amounting to 6.3266 million yuan, which represented 2.17% of the total trading volume for the day. The transaction price was 7.65 yuan, reflecting an 11.87% discount compared to the market closing price of 8.68 yuan [1] Group 1 - The block trade involved a total of 827,000 shares at a price of 7.65 yuan per share [1] - The total transaction value was 6.3266 million yuan [1] - The discount of 11.87% indicates a significant deviation from the market closing price [1] Group 2 - The trading volume included multiple transactions with different brokerage firms, such as Guotai Junan Securities and Western Securities [2] - Specific transaction details include a volume of 26.20 million shares for a total of 200.43 million yuan, and 30.00 million shares for 229.50 million yuan [2] - The trades were executed on the same day, indicating active trading interest in Xilong Science [2]

Group 1 - The core transaction involved 840,000 shares of Xilong Science, with a total transaction value of 6.51 million yuan, accounting for 4.9% of the total trading volume on that day [1] - The transaction price was 7.75 yuan per share, representing a discount of 10.51% compared to the market closing price of 8.66 yuan [1]

Core Viewpoint - The announcement details a reduction in shareholding by the controlling shareholders of Xilong Science, which does not affect the company's control or daily operations [3][4]. Group 1: Shareholding Changes - The controlling shareholders, including Huang Weibao, Huang Weipeng, Huang Zhenkai, and Huang Zhenjie, have reduced their total shareholding from 146,304,022 shares to 140,451,388 shares, resulting in a decrease in their holding percentage from 25.000% to 24.000% [3][4]. - This reduction in shareholding touches the 1% integer multiple threshold, which necessitates the announcement [3][4]. - The shareholders plan to reduce their holdings by up to 17,556,400 shares, not exceeding 3.00% of the total share capital, through centralized bidding and block trading within three months following the pre-disclosure announcement [3][4]. Group 2: Compliance and Disclosure - The company confirms that the content of the announcement is consistent with the information provided by the obligated information disclosers [2]. - The reduction in shareholding has been pre-disclosed in accordance with relevant regulations, and the actual reduction aligns with previously disclosed intentions and commitments [3][4].

Core Viewpoint - The controlling shareholders of Xilong Science have reduced their stake in the company by 1%, selling a total of 5,852,634 shares between November 6 and November 13, 2025 [1] Summary by Sections - **Shareholder Reduction** - The controlling shareholders, including Huang Weibao, Huang Weipeng, Huang Zhenkai, and Huang Zhenjie, have collectively reduced their holdings from 146,304,022 shares to 140,451,388 shares [1] - **Percentage Change** - The total shareholding percentage of the controlling shareholders and their concerted actions decreased from 25.000% to 24.000% following the reduction [1]

Summary of Key Points Core Viewpoint - On November 13, Xilong Science executed a block trade of 1.35 million shares, amounting to 10.34 million yuan, which represented 3.98% of the total trading volume for the day. The transaction price was 7.66 yuan, reflecting an 11.85% discount compared to the market closing price of 8.69 yuan [1]. Group 1: Trading Details - The block trade involved a total of 135,000 shares at a price of 7.66 yuan per share [1]. - The total transaction value for the block trade was 10.34 million yuan [1]. - The trade accounted for 3.98% of the total trading volume on that day [1]. Group 2: Buyer and Seller Information - The buyer of the shares was identified as an institutional trading department, specifically from Guotai Junan Securities [2]. - The seller was associated with Guolian Minsheng Securities [2]. - The transaction included multiple trading departments, indicating a structured approach to the trade [2].

Core Insights - On November 11, 2025, Xilong Science executed a block trade of 520,000 shares, amounting to 4.004 million yuan, which represented 1.6% of the total trading volume for the day [1] - The transaction price was 7.70 yuan per share, reflecting a discount of 10.67% compared to the market closing price of 8.62 yuan [1] Summary by Category - **Transaction Details** - Date: November 11, 2025 - Security Code: 002584 - Security Name: Xilong Science - Transaction Price: 7.70 yuan - Transaction Volume: 520,000 shares (26 million shares) - Total Transaction Amount: 4.004 million yuan [2] - **Brokerage Information** - Buyer Brokerage: Zhongtai Securities Co., Ltd. and Great Wall Securities Co., Ltd. - Seller Brokerage: Guolian Jusheng Securities Co., Ltd. and Guolian Minsheng Securities Co., Ltd. [2]

Group 1 - The core issue involves a lawsuit against the company regarding securities false statement liability, with the company being the appellant in the case [2][3][4] - The first-instance judgment determined that the company must pay a compensation amount of 7.5701 million yuan (excluding litigation fees) [3] - The company has recognized a provision for expected liabilities of 13.1131 million yuan in its 2024 annual report, which is expected to cover all related losses from the lawsuits [3][8] Group 2 - The company has withdrawn its appeal during the second-instance trial, and the first-instance judgment has become legally effective [4][5] - The company has received other related lawsuits, including one with a claim amount of approximately 8.0409 million yuan and another for about 496,598.89 yuan, both of which are still pending judgment [7] - The potential financial impact of the lawsuits is minimal, with the recognized expected liabilities representing about 0.28% of the company's total audited assets and 0.57% of its net assets [8] Group 3 - The company's wholly-owned subsidiary, Sichuan Xilong Science Co., Ltd., has been recognized as a "specialized, refined, characteristic, and innovative" small and medium-sized enterprise in Sichuan Province, effective from October 23, 2025, to October 31, 2028 [11][12] - This recognition reflects the subsidiary's strong innovation capabilities and focus on niche markets, contributing positively to the company's future development [12][13] - The recognition is not expected to have a significant impact on the company's current operating performance [13]

Core Viewpoint - Xilong Science (002584.SZ) announced that its wholly-owned subsidiary, Sichuan Xilong Science Co., Ltd., has been recognized as a specialized and innovative small and medium-sized enterprise in Sichuan Province for the year 2025, with a validity period from October 23, 2025, to October 31, 2028 [1] Company Summary - Sichuan Xilong has been included in the list of newly recognized and re-evaluated specialized and innovative small and medium-sized enterprises by the Sichuan Provincial Economic and Information Technology Department [1]